Stock listing
Euronext:ALOPM Oncodesign Precision Medicine S.A. Action
Home listing (Euronext) of Oncodesign Precision Medicine S.A.
Follow Oncodesign Precision Medicine S.A. into a list and get an email when it puts out news.
Share price · EURONEXT:ALOPM
€0.26 EUR +0.02 (+8.3%)
Close on Oct 30, 2026
- Day range
- €0.24 – €0.26 EUROct 30, 2026
- Volume
- 23,390 sharesOct 30, 2026
- Market cap
- €4.96M EURAt the close on Oct 30, 2026 · price × 19.07M shares outstanding
- 52-week range
- €0.20 – €0.92 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- €6,550 EURMedian day 14,041 shares · 1 day with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ALOPM · Home | €0.26 EUR | +0.02 (+8.3%) | 23,390 | €0.24 | €0.26 | €0.24 | €0.24 | Close on Oct 30, 2026 |
| Frankfurt:ZR8 | €0.228 EUR | +0.007 (+3.2%) | — | €0.216 | €0.228 | €0.216 | €0.221 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · EURONEXT:ALOPM · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.26 | +0.02 | +8.3% | €0.24 | €0.26 | €0.24 | 23,390 | |
| €0.24 | -0.007 | -2.8% | €0.24 | €0.25 | €0.236 | 17,900 | |
| €0.247 | -0.003 | -1.2% | €0.249 | €0.25 | €0.247 | 27,785 | |
| €0.25 | -0.006 | -2.3% | €0.255 | €0.258 | €0.23 | 62,996 | |
| €0.256 | -0.034 | -11.7% | €0.29 | €0.29 | €0.256 | 28,366 | |
| €0.29 | -0.037 | -11.3% | €0.328 | €0.328 | €0.29 | 47,225 | |
| €0.327 | +0.007 | +2.2% | €0.33 | €0.33 | €0.304 | 21,229 | |
| €0.32 | -0.01 | -3.0% | €0.329 | €0.329 | €0.32 | 1,043 | |
| €0.33 | +0.02 | +6.5% | €0.32 | €0.33 | €0.319 | 1,552 | |
| €0.31 | -0.031 | -9.1% | €0.34 | €0.348 | €0.31 | 10,432 | |
| €0.341 | +0.021 | +6.6% | €0.331 | €0.341 | €0.33 | 3,400 | |
| €0.32 | -0.03 | -8.6% | €0.349 | €0.349 | €0.32 | 25,102 | |
| €0.35 | +0.012 | +3.6% | €0.33 | €0.35 | €0.33 | 17,900 | |
| €0.338 | -0.011 | -3.2% | €0.322 | €0.35 | €0.322 | 33,730 | |
| €0.349 | +0.019 | +5.8% | €0.32 | €0.35 | €0.32 | 32,471 | |
| €0.33 | -0.025 | -7.0% | €0.355 | €0.356 | €0.33 | 44,535 | |
| €0.355 | +0.022 | +6.6% | €0.36 | €0.37 | €0.34 | 31,522 | |
| €0.333 | 0.00 | 0.0% | €0.334 | €0.35 | €0.333 | 12,118 | |
| €0.333 | -0.047 | -12.4% | €0.38 | €0.38 | €0.333 | 14,966 | |
| €0.38 | 0.00 | 0.0% | €0.38 | €0.385 | €0.38 | 0 | |
| €0.38 | +0.001 | +0.3% | €0.38 | €0.385 | €0.38 | 7,964 | |
| €0.379 | -0.004 | -1.0% | €0.379 | €0.38 | €0.36 | 19,469 | |
| €0.383 | +0.013 | +3.5% | €0.36 | €0.383 | €0.36 | 26,405 | |
| €0.37 | +0.024 | +6.9% | €0.36 | €0.37 | €0.336 | 16,516 | |
| €0.346 | -0.02 | -5.5% | €0.35 | €0.35 | €0.315 | 14,111 | |
| €0.366 | +0.056 | +18.1% | €0.279 | €0.369 | €0.279 | 215,448 | |
| €0.31 | +0.054 | +21.1% | €0.271 | €0.31 | €0.26 | 45,065 | |
| €0.256 | +0.012 | +4.9% | €0.258 | €0.31 | €0.25 | 84,450 | |
| €0.244 | +0.014 | +6.1% | €0.231 | €0.246 | €0.231 | 5,593 | |
| €0.23 | -0.016 | -6.5% | €0.245 | €0.245 | €0.23 | 845 | |
| €0.246 | +0.009 | +3.8% | €0.237 | €0.246 | €0.23 | 21,826 | |
| €0.237 | +0.017 | +7.7% | €0.21 | €0.237 | €0.21 | 13,335 | |
| €0.22 | +0.02 | +10.0% | €0.211 | €0.23 | €0.20 | 31,615 | |
| €0.20 | -0.015 | -7.0% | €0.216 | €0.224 | €0.20 | 6,177 | |
| €0.215 | -0.016 | -6.9% | €0.229 | €0.229 | €0.215 | 1,801 | |
| €0.231 | -0.008 | -3.3% | €0.238 | €0.239 | €0.215 | 49,088 | |
| €0.239 | +0.019 | +8.6% | €0.234 | €0.257 | €0.234 | 26,579 | |
| €0.22 | -0.025 | -10.2% | €0.245 | €0.245 | €0.22 | 29,941 | |
| €0.245 | +0.005 | +2.1% | €0.23 | €0.245 | €0.22 | 49,802 | |
| €0.24 | -0.005 | -2.0% | €0.243 | €0.244 | €0.23 | 16,012 | |
| €0.245 | +0.02 | +8.9% | €0.231 | €0.245 | €0.23 | 9,255 | |
| €0.225 | -0.025 | -10.0% | €0.25 | €0.25 | €0.225 | 4,379 | |
| €0.25 | +0.001 | +0.4% | €0.257 | €0.258 | €0.25 | 8,486 | |
| €0.249 | -0.001 | -0.4% | €0.25 | €0.258 | €0.232 | 29,582 | |
| €0.25 | -0.029 | -10.4% | €0.27 | €0.278 | €0.25 | 88,910 | |
| €0.279 | -0.002 | -0.7% | €0.28 | €0.282 | €0.26 | 60,489 | |
| €0.281 | -0.036 | -11.4% | €0.317 | €0.317 | €0.281 | 65,301 | |
| €0.317 | -0.002 | -0.6% | €0.319 | €0.319 | €0.306 | 1,429 | |
| €0.319 | -0.003 | -0.9% | €0.319 | €0.319 | €0.319 | 201 | |
| €0.322 | +0.001 | +0.3% | €0.31 | €0.327 | €0.302 | 17,261 | |
| €0.321 | -0.005 | -1.5% | €0.32 | €0.326 | €0.32 | 908 | |
| €0.326 | +0.01 | +3.2% | €0.321 | €0.326 | €0.32 | 4,730 | |
| €0.316 | +0.002 | +0.6% | €0.316 | €0.325 | €0.315 | 1,470 | |
| €0.314 | -0.011 | -3.4% | €0.304 | €0.327 | €0.304 | 14,041 | |
| €0.325 | +0.005 | +1.6% | €0.32 | €0.327 | €0.32 | 3,087 | |
| €0.32 | -0.006 | -1.8% | €0.326 | €0.327 | €0.32 | 2,083 | |
| €0.326 | 0.00 | 0.0% | €0.327 | €0.327 | €0.326 | 1,035 | |
| €0.326 | -0.001 | -0.3% | €0.328 | €0.328 | €0.326 | 841 | |
| €0.327 | +0.007 | +2.2% | €0.32 | €0.328 | €0.312 | 6,700 | |
| €0.32 | -0.002 | -0.6% | €0.32 | €0.328 | €0.32 | 3,828 | |
| €0.322 | +0.001 | +0.3% | €0.322 | €0.328 | €0.322 | 1,179 | |
| €0.321 | -0.019 | -5.6% | €0.318 | €0.321 | €0.318 | 7,015 | |
| €0.34 | +0.029 | +9.3% | €0.313 | €0.341 | €0.313 | 7,458 | |
| €0.311 | -0.001 | -0.3% | €0.311 | €0.311 | €0.311 | 22 | |
| €0.312 | -0.01 | -3.1% | €0.319 | €0.32 | €0.312 | 269 | |
| €0.322 | +0.01 | +3.2% | €0.312 | €0.322 | €0.312 | 5,046 | |
| €0.312 | +0.001 | +0.3% | €0.31 | €0.326 | €0.31 | 950 |
- Ticker
- Euronext:ALOPM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Euronext
- Currency
- EUR
What changed lately
Latest news release · Oct 22, 2026
OPM Announces Its 2026 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position
Latest news
OPM Announces Its 2026 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position
Oct 22, 2026
Closed €0.327 (+2.2%) on Oct 22, 2026
OPM Achieved Several Major Scientific and Regulatory Milestones as Part of the LARKIN Program, Supported With Funding By The Michael J. Fox Foundation for Parkinson's Research (MJFF)
Oct 7, 2026
Closed €0.355 (+6.6%) on Oct 8, 2026
OPM Announces Its 2025 Annual Results and Provides an Update on Its Clinical Developments
Apr 30, 2026
Closed €0.458 (+4.1%) on May 4, 2026
Oncodesign Precision Medicine Receives Support from The Michael J. Fox Foundation to Advance Development of LRRK2 Inhibitor OPM-201 for Parkinson’s Disease
Mar 3, 2026
Closed €0.664 (+44.3%) on Mar 4, 2026
Oncodesign Precision Medicine and Ksilink Join Forces to Test the Nanocyclix® Chemical Library in Cell Models Derived From Patients With Serious Central Nervous System Diseases
Jan 8, 2026
Closed €0.84 (+64.7%) on Jan 9, 2026
Oncodesign Precision Medicine and Navigo Proteins Announce the End of Their Collaboration in the Development of Radiotheranostics
Dec 29, 2025
Closed €0.409 (+7.3%) on Dec 30, 2025
Decks
Investor Day (December 2023)
Investor day · 62 slides · Dec 5, 2023
Oncodesign Precision Medicine S.A. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 7 in the last 12 months · 21 in all · newest Oct 22, 2026 · oldest 2024
- Decks
- 1 deck · latest Dec 5, 2023
Where Oncodesign Precision Medicine S.A. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ALOPM · Home listing · This page | Euronext | France | EUR |
| Lang & Schwarz:A3DVNM | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3DVNM | LS Exchange | Germany | EUR |
| Frankfurt:ZR8 | Frankfurt | Germany | EUR |
| Stuttgart:ZR8 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Oncodesign Precision Medicine S.A.